These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 3643509)
21. Abnormalities of lymphocyte subsets and anti-LAV/HTLV-III status in Greek hemophiliacs. Choremi H; Economidou J; Psarra K; Sidiri E; Mandalaki T; Louizou C; Gialeraki A; Markakis C; Papaevangelou C; Kallinicos G AIDS Res; 1986; 2(4):271-7. PubMed ID: 3101712 [TBL] [Abstract][Full Text] [Related]
22. Detection of antibodies to HTLV-I and -III in sera from Japanese hemophiliacs. Abe T; Kinoshita T; Matsuda J; Ryu T; Ting RC; Aoki T; Robert-Guroff M; Miyakoshi H; Gallo RC Cancer Res; 1985 Sep; 45(9 Suppl):4621s-4623s. PubMed ID: 2990696 [TBL] [Abstract][Full Text] [Related]
23. [Importance of blood and its components in the prevalence of human immunodeficiency virus]. Altafulla M; Vázquez de Bernal J Rev Med Panama; 1986 Sep; 11(3):188-92. PubMed ID: 3492734 [No Abstract] [Full Text] [Related]
24. Hemophiliacs and acquired immune deficiency syndrome. Lin TA; Zhao JQ; Rabin B Chin Med J (Engl); 1985 Jun; 98(6):444-6. PubMed ID: 2996841 [No Abstract] [Full Text] [Related]
25. [Retrospective serological analysis of HTLV-III/LAV antibody and immunity in hemophiliac patients in Shizuoka Prefecture]. Mimaya J; Tonouchi T; Toyoda Y; Sugiyama T; Sonoda A; Fukuda F; Hattori T; Takatsuki K Rinsho Ketsueki; 1986 Jun; 27(6):866-71. PubMed ID: 3463806 [No Abstract] [Full Text] [Related]
26. [Preventive measures against HTLV-III/LAV infections among hemophiliacs and their relatives]. Evensen SA; Frøland SS; Glomstein A Tidsskr Nor Laegeforen; 1986 Jan; 106(1):19-21. PubMed ID: 3006278 [No Abstract] [Full Text] [Related]
27. HTLV-III/LAV antibody and immune status of household contacts and sexual partners of persons with hemophilia. Jason JM; McDougal JS; Dixon G; Lawrence DN; Kennedy MS; Hilgartner M; Aledort L; Evatt BL JAMA; 1986 Jan; 255(2):212-5. PubMed ID: 3001375 [TBL] [Abstract][Full Text] [Related]
28. [Anti-HTLV-III/Lav antibodies, clinical symptoms and immunological determinations in hemophilia patients in Buenos Aires]. Anselmo A; Muchinik G; Pérez Bianco R; de la Barrera S; Riera NE; de Bracco MM; de Tezanos Pinto M Medicina (B Aires); 1985; 45(3):312-3. PubMed ID: 3870213 [No Abstract] [Full Text] [Related]
29. Human T-lymphotropic retrovirus type III/lymphadenopathy-associated virus antibody. Association with hemophiliacs' immune status and blood component usage. Jason J; McDougal JS; Holman RC; Stein SF; Lawrence DN; Nicholson JK; Dixon G; Doxey M; Evatt BL JAMA; 1985 Jun; 253(23):3409-15. PubMed ID: 2987559 [TBL] [Abstract][Full Text] [Related]
30. [Transmission of AIDS virus by transfusion and blood products. Risks and preventive strategies]. Habibi B Rev Epidemiol Sante Publique; 1986; 34(2):118-25. PubMed ID: 3016831 [TBL] [Abstract][Full Text] [Related]
31. Survey of the prevalence of AIDS-associated virus (LAV) infection in Japan. Tsuchie H; Kurimura T; Hinuma Y J Infect; 1985 May; 10(3):272-6. PubMed ID: 2993425 [TBL] [Abstract][Full Text] [Related]
32. HTLV-III/LAV-seronegative, virus-negative sexual partners and household contacts of hemophiliacs. McFadden T; Jason JM; Feorino P JAMA; 1986 Apr; 255(13):1702. PubMed ID: 3005673 [No Abstract] [Full Text] [Related]
33. Natural history of primary infection with LAV in multitransfused patients. By the AIDS-Hemophilia French Study Group. Blood; 1986 Jul; 68(1):89-94. PubMed ID: 3013344 [TBL] [Abstract][Full Text] [Related]
34. HTLV-III/LAV antibodies in contacts of hemophiliacs. Girón JA JAMA; 1986 Jun; 255(23):3246. PubMed ID: 3486985 [No Abstract] [Full Text] [Related]
35. Anti-LAV/HTLV-III antibodies in groups of individuals at high risk for infection in Italy. Zanetti AR; Ferroni P; Colombo M; Cargnel A; Mari D; Zehender G; Rumi MG; Gringeri A; Ammassari M; Mannucci PM Ric Clin Lab; 1985; 15(4):357-64. PubMed ID: 3914699 [TBL] [Abstract][Full Text] [Related]
36. Occurrence of AIDS in hemophiliacs in Japan. Abe T; Kazama M; Kinoshita T; Matuda J; Yoshimura Y; Ryu T; Takahashi I Semin Thromb Hemost; 1985 Oct; 11(4):352-6. PubMed ID: 4071060 [TBL] [Abstract][Full Text] [Related]
37. HTLV-I antibody status in hemophilia patients treated with factor concentrates prepared from U.S. plasma sources and in hemophilia patients with AIDS. Chorba TL; Jason JM; Ramsey RB; Lechner K; Pabinger-Fasching I; Kalyanaraman VS; McDougal JS; Cabradilla CD; Tregillus LC; Lawrence DN Thromb Haemost; 1985 Apr; 53(2):180-2. PubMed ID: 2992112 [TBL] [Abstract][Full Text] [Related]
38. Immune impairments and antibodies to HTLVIII/LAV in asymptomatic male homosexuals in Israel: relevance to the risk of acquired immune deficiency syndrome (AIDS). Bentwich Z; Saxinger C; Ben-Ishay Z; Burstein R; Berner Y; Pecht M; Trainin N; Levin S; Handzel ZT J Clin Immunol; 1987 Sep; 7(5):376-80. PubMed ID: 2443528 [TBL] [Abstract][Full Text] [Related]
39. Australian hemophiliac recipients of voluntary donor blood products longitudinally evaluated for AIDS. A clinical and laboratory study, 1983-1986. Garsia RJ; Gatenby PA; Basten A; Kenny DF; Gallagher KJ; Rickard KA; Gust ID; Maskill W Aust N Z J Med; 1987 Aug; 17(4):371-8. PubMed ID: 2963611 [TBL] [Abstract][Full Text] [Related]
40. [Transfusion-associated LAV/HTLV-III infections in Switzerland. Report of 2 cases]. Flepp M; Täuber MG; Lüthy R; Frauchiger B; Barandun J; Schütze M; Joller H; Frey-Wettstein M; Vetter W; Siegenthaler W Schweiz Med Wochenschr; 1986 Apr; 116(14):426-8. PubMed ID: 3008323 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]